Company Filing History:
Years Active: 2003-2017
Title: Guido Paesen: Innovator in Dendritic Cell Modulation and Tissue Adhesion
Introduction
Guido Paesen is a notable inventor based in Oxford, GB. He has made significant contributions to the field of immunology and biotechnology, particularly through his innovative patents. With a total of 3 patents, Paesen's work focuses on the modulation of dendritic cells and the development of tissue cement proteins.
Latest Patents
One of Paesen's latest patents involves dendritic cell inhibitory proteins derived from ticks. This invention provides a dendritic cell modulatory protein that modulates, and preferably inhibits, the differentiation and/or maturation of mammalian dendritic cells. The patent also includes proteins comprising conserved motifs found in such proteins, as well as pharmaceutical compositions that utilize these proteins, homologs, fragments, and antibodies for treatment methods. Another significant patent relates to tissue cement proteins produced by certain species of blood-feeding ectoparasites. These proteins are particularly useful for the temporary or permanent bonding of animal tissues to each other or to other biomaterials. Additionally, this invention addresses the use of tissue cement proteins in the production of vaccines that protect animals against the bites of blood-sucking ectoparasites and the transmission of various pathogens.
Career Highlights
Throughout his career, Guido Paesen has worked with prominent companies such as Merial Limited and Oxford Vacs Ltd. His expertise in the field has allowed him to contribute to advancements in veterinary medicine and immunology.
Collaborations
Paesen has collaborated with notable colleagues, including Patricia Ann Nuttall and Jonathan M Austyn. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Guido Paesen's innovative work in dendritic cell modulation and tissue adhesion has made a significant impact in biotechnology and immunology. His patents reflect a commitment to advancing medical science and improving treatment options for various conditions.
